Search Results - "Basoglu, Tugba"

Triple-Negative Apocrine Carcinoma: Largest Cohort Highlights Unique Biology and Survival Advantage.

Authors: Basoglu, Tugba Ozkerim, Ugur Oksuz, Sila et al.

Source: Journal of Clinical Medicine. Oct2025, Vol. 14 Issue 19, p7103. 16p.

A rare case of gastric cancer with bilateral breast metastasis during pregnancy.

Authors: Basoglu, Tugba Telli, Tugba Akin Demircan, Nazim Can et al.

Source: Journal of Oncology Pharmacy Practice. Jan2021, Vol. 27 Issue 1, p220-226. 7p.

Association Between Time to PSA Nadir, Radiologic Progression, and PSA Progression in mHSPC Patients Treated with Abiraterone or Enzalutamide.

Authors: Ozkerim, Ugur Kinikoglu, Oguzcan Isik, Deniz et al.

Source: Journal of Clinical Medicine. Jan2026, Vol. 15 Issue 1, p386. 15p.

Impact of Age and Menopausal Status on T-DM1 (Ado-Trastuzumab Emtansine) Treatment Outcomes in HER2-Positive Breast Cancer.

Authors: Surmeli, Heves Isik, Deniz Kinikoglu, Oguzcan et al.

Source: Pharmaceuticals (14248247). Jun2025, Vol. 18 Issue 6, p931. 14p.

Evaluating the Effectiveness of Nivolumab in Metastatic Lung Cancer Among Patients Aged 65 and Older.

Authors: Isik, Deniz Alan, Özkan Akdağ, Goncagül et al.

Source: Journal of Clinical Medicine. Oct2024, Vol. 13 Issue 20, p6263. 12p.

A Novel Prognostic Indicator for Immunotherapy Response: Lymphocyte-to-Albumin (LA) Ratio Predicts Survival in Metastatic NSCLC Patients.

Authors: Yildirim, Sedat Dogan, Akif Akdag, Goncagul et al.

Source: Cancers. Jul2024, Vol. 16 Issue 14, p2512. 10p.

Association between GRIm score and response to nivolumab monotherapy in patients with advanced malignant melanoma.

Authors: Oksuz, Sila Kinikoglu, Oguzcan Ozkerim, Ugur et al.

Source: Journal of Cancer Research & Clinical Oncology. Jan2026, Vol. 152 Issue 1, p1-8. 8p.

Development of a Machine Learning-Based Prognostic Model Using Systemic Inflammation Markers in Patients Receiving Nivolumab Immunotherapy: A Real-World Cohort Study.

Authors: Ozkerim, Ugur Isik, Deniz Kinikoglu, Oguzcan et al.

Source: Journal of Personalized Medicine. Jan2026, Vol. 16 Issue 1, p8. 17p.

Prognostic Value of Body Composition in Therapy-Naive Patients with Non-Small Cell Lung Cancer.

Authors: YOLCU, Tugba Kiratli KESIM, Selin FILIZOGLU, Nuh et al.

Source: UHOD: International Journal of Hematology & Oncology / Uluslararasi Hematoloji Onkoloji Dergisi. 2024, Vol. 34 Issue 1, p1-9. 9p.

Is insulin resistance a predictor for complete response in breast cancer patients who underwent neoadjuvant treatment?

Authors: Alan, Ozkan Akin Telli, Tugba Aktas, Bilge et al.

Source: World Journal of Surgical Oncology. 9/9/2020, Vol. 18 Issue 1, p1-9. 9p.

Prognostic significance of 18F-FDG PET/CT indices in metastatic renal cell cancer and evaluation of revised IMDC risk model by including 18F-FDG PET-CT parameters.

Authors: Arikan, Rukiye Ozguven, Salih Telli, Tugba Akin et al.

Source: Acta Radiologica. May2023, Vol. 64 Issue 5, p2040-2049. 10p.

Real-life comparison of the afatinib and first-generation tyrosine kinase inhibitors in nonsmall cell lung cancer harboring EGFR exon 19 deletion: a Turk Oncology Group (TOG) study.

Authors: Bilgin, Burak Sendur, Mehmet Ali Nahit Yucel, Sebnem et al.

Source: Journal of Cancer Research & Clinical Oncology. Jul2021, Vol. 147 Issue 7, p2145-2152. 8p.

How long should we continue crizotinib in ALK translocation-positive inflammatory myofibroblastic tumors? Long-term complete response with crizotinib and review of the literature.

Authors: Alan, Ozkan Kuzhan, Okan Koca, Sinan et al.

Source: Journal of Oncology Pharmacy Practice. Jun2020, Vol. 26 Issue 4, p1011-1018. 8p. 2 Color Photographs, 2 Black and White Photographs, 2 Charts.

Adrenocortical Cancer in the Real World: A Comprehensive Analysis of Clinical Features and Management from the Turkish Oncology Group (TOG).

Authors: Yasar, Hatime Arzu Aktas, Burak Yasin Ucar, Gokhan et al.

Source: Clinical Genitourinary Cancer. Jun2024, Vol. 22 Issue 3, pN.PAG-N.PAG. 1p.

Evolving treatment strategies for HER2-altered non-small-cell lung cancer: the rise of TKIs and ADCs.

Authors: Balli S Basoglu T Ozdogan M

Source: Frontiers in oncology [Front Oncol] 2026 Mar 25; Vol. 16, pp. 1771869. Date of Electronic Publication: 2026 Mar 25 (Print Publication: 2026).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Significance of CEA Dynamics and Systemic Inflammatory Markers in HER2-Positive Metastatic Colorectal Cancer Patients Undergoing First-Line Chemotherapy: A Real-World Cohort Study.

Authors: Ozkerim U Kinikoglu O Oksuz S et al.

Source: Medicina (Kaunas, Lithuania) [Medicina (Kaunas)] 2026 Jan 02; Vol. 62 (1). Date of Electronic Publication: 2026 Jan 02.

Publication Type: Journal Article

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 9425208 Publication Model: Electronic Cited Medium: Internet ISSN: 1648-9144 (Electronic) Linking ISSN: 1010660X NLM ISO Abbreviation: Medicina (Kaunas) Subsets: MEDLINE

The Association of Khorana Risk Score with Venous Thromboembolism and Overall Survival in Patients with Metastatic Gastric Cancer.

Authors: Turkoglu E Topal GA Yıldırım S et al.

Source: Medicina (Kaunas, Lithuania) [Medicina (Kaunas)] 2025 Jun 11; Vol. 61 (6). Date of Electronic Publication: 2025 Jun 11.

Publication Type: Journal Article

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 9425208 Publication Model: Electronic Cited Medium: Internet ISSN: 1648-9144 (Electronic) Linking ISSN: 1010660X NLM ISO Abbreviation: Medicina (Kaunas) Subsets: MEDLINE

Prognostic Impact and Clinicopathological Correlates of HER2 Status in Gastric Cancer: A Multicenter Retrospective Turkish Oncology Group Study.

Authors: Yildirim S Sever ON Turkoglu E et al.

Source: Clinical Medicine Insights. Oncology [Clin Med Insights Oncol] 2026 May 06; Vol. 20, pp. 11795549261445290. Date of Electronic Publication: 2026 May 06 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: SAGE Publications Country of Publication: United States NLM ID: 101525771 Publication Model: eCollection Cited Medium: Print ISSN: 1179-5549 (Print) Linking ISSN: 11795549 NLM ISO Abbreviation: Clin Med Insights Oncol Subsets: PubMed not MEDLINE

Impact of HER2 Status Assessed by Immunohistochemistry on Treatment Response in Patients with Metastatic Breast Cancer Receiving Trastuzumab Emtansine.

Authors: Oksuz S Kinikoglu O Ozkerim U et al.

Source: Medicina (Kaunas, Lithuania) [Medicina (Kaunas)] 2025 Apr 29; Vol. 61 (5). Date of Electronic Publication: 2025 Apr 29.

Publication Type: Journal Article

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 9425208 Publication Model: Electronic Cited Medium: Internet ISSN: 1648-9144 (Electronic) Linking ISSN: 1010660X NLM ISO Abbreviation: Medicina (Kaunas) Subsets: MEDLINE

Prognostic Impact and Clinical Features of Spread through Air Spaces in Operated Lung Cancer: Real-World Analysis.

Authors: Yildirim S Alan O Yuksel Yasar Z et al.

Source: Medicina (Kaunas, Lithuania) [Medicina (Kaunas)] 2024 Aug 22; Vol. 60 (8). Date of Electronic Publication: 2024 Aug 22.

Publication Type: Journal Article

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 9425208 Publication Model: Electronic Cited Medium: Internet ISSN: 1648-9144 (Electronic) Linking ISSN: 1010660X NLM ISO Abbreviation: Medicina (Kaunas) Subsets: MEDLINE